SANTILLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 11.799
EU - Europa 6.926
AS - Asia 6.512
Continente sconosciuto - Info sul continente non disponibili 1.160
SA - Sud America 859
AF - Africa 96
OC - Oceania 4
Totale 27.356
Nazione #
US - Stati Uniti d'America 11.388
SG - Singapore 2.658
CN - Cina 1.697
RU - Federazione Russa 1.420
IT - Italia 1.068
IE - Irlanda 956
UA - Ucraina 788
TR - Turchia 704
SE - Svezia 701
BR - Brasile 675
VN - Vietnam 606
GB - Regno Unito 604
DE - Germania 415
FR - Francia 411
IN - India 267
FI - Finlandia 250
CA - Canada 183
BD - Bangladesh 121
HK - Hong Kong 121
MX - Messico 78
AR - Argentina 72
PL - Polonia 66
NL - Olanda 56
JP - Giappone 52
IQ - Iraq 42
ZA - Sudafrica 35
AT - Austria 34
ES - Italia 33
ID - Indonesia 33
JM - Giamaica 26
KR - Corea 25
PK - Pakistan 25
VE - Venezuela 25
CO - Colombia 24
EC - Ecuador 20
SA - Arabia Saudita 20
BE - Belgio 19
CR - Costa Rica 19
CZ - Repubblica Ceca 19
TT - Trinidad e Tobago 17
LT - Lituania 16
MA - Marocco 16
CL - Cile 14
HN - Honduras 14
PH - Filippine 14
AZ - Azerbaigian 13
NI - Nicaragua 13
UZ - Uzbekistan 13
SV - El Salvador 12
EU - Europa 11
IR - Iran 11
MY - Malesia 11
AL - Albania 10
EE - Estonia 10
GT - Guatemala 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
GP - Guadalupe 9
JO - Giordania 9
PY - Paraguay 8
RO - Romania 8
EG - Egitto 7
LB - Libano 7
PE - Perù 7
UY - Uruguay 7
ET - Etiopia 6
NG - Nigeria 6
OM - Oman 6
QA - Qatar 6
CH - Svizzera 5
CW - ???statistics.table.value.countryCode.CW??? 5
KE - Kenya 5
PR - Porto Rico 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
BZ - Belize 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HU - Ungheria 4
NP - Nepal 4
PA - Panama 4
RS - Serbia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BG - Bulgaria 3
BM - Bermuda 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
Totale 26.183
Città #
Singapore 2.039
San Jose 1.398
Chandler 1.086
Jacksonville 960
Dublin 940
Ashburn 915
Dallas 552
Beijing 462
Council Bluffs 443
Princeton 383
Southend 370
Izmir 336
Los Angeles 334
Santa Clara 260
Nanjing 235
Ho Chi Minh City 206
Dearborn 205
New York 199
The Dalles 192
Wilmington 187
Cambridge 159
Buffalo 153
Ann Arbor 144
Hanoi 143
Altamura 135
Chieti 117
Hong Kong 109
Moscow 103
Munich 103
Nanchang 99
Tongling 99
Boardman 90
Pescara 82
Phoenix 81
Washington 80
North Bergen 72
São Paulo 71
Orem 65
Helsinki 61
Montreal 61
Brooklyn 59
Redondo Beach 57
Shenyang 49
Hebei 48
Kunming 47
Tokyo 47
Woodbridge 45
Rome 44
Atlanta 43
Milan 43
Tianjin 42
Chicago 41
Warsaw 39
Denver 38
Stockholm 34
Toronto 34
Columbus 33
Turku 33
Chennai 32
Changsha 31
Jiaxing 31
London 31
Frankfurt am Main 30
Grevenbroich 30
Mexico City 30
Seattle 30
Hefei 29
Norwalk 29
Poplar 28
Augusta 27
Houston 27
Johannesburg 27
Kimball 26
San Francisco 26
Amsterdam 24
Kingston 23
Seoul 23
Da Nang 22
Nuremberg 22
Manchester 21
Boston 20
Ankara 19
Hangzhou 19
Naples 19
Dong Ket 18
Jinan 18
League City 18
Shanghai 18
Brussels 17
Changchun 17
Lanzhou 17
Mount Pleasant 17
Mumbai 17
San José 17
San Mateo 17
Rio de Janeiro 16
Belo Horizonte 15
Charlotte 15
Falls Church 15
Vienna 15
Totale 15.448
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 894
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 213
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 202
Pentraxin 3 and platelet activation in obese patients after gastric banding 190
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 188
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 187
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 183
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 178
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 178
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 176
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 174
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 171
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 169
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 166
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 166
Role of growth factors in the development of diabetic complications 165
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 165
Determinants of platelet activation in hypertensives with microalbuminuria. 164
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 164
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 159
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 159
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 158
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 157
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 157
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 155
Neurocognitive impairment and suicide risk among prison inmates 155
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 155
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 153
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 153
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 153
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 153
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 151
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 150
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 149
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 149
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 149
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 149
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 149
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 148
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 148
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 147
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 147
Platelets and Diabetes 147
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 146
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 146
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 144
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 143
COVID-19 and RAS: Unravelling an Unclear Relationship 143
Platelet activation in obesity and metabolic syndrome. 142
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 142
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 142
Aspirin, platelets, and cancer: The point of view of the internist. 141
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 141
Insulin resistance as a determinant of platelet activation in obese women. 140
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 140
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 139
Coagulation and infective endocarditis: sooner or later 139
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 139
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 139
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 138
The role of antileukotrienes in the treatment of asthma. 137
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 137
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 137
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 137
Platelets and diabetes mellitus 137
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 137
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 136
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 135
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 135
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 135
Soluble RAGE in type 2 diabetes: association with oxidative stress. 134
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 134
Soluble forms of RAGE in internal medicine. 134
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 132
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 132
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 132
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 131
Determinants of platelet activation in hypertensives with microalbuminuria. 131
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study 131
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 131
Kinetics of Circulating Extracellular Vesicles Over the 24-Hour Dosing Interval After Low-Dose Aspirin Administration in Patients at Cardiovascular Risk 130
The role of nitric oxide in the development of diabetic angiopathy. 130
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 130
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 130
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 129
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 128
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 126
Association between PAI-1 and Oxidative Stress in Android Obesity 126
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 126
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 125
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 125
The left atrial appendage: from embryology to prevention of thromboembolism 125
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 124
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 124
Correlation between Migraine Severity and Cholesterol Levels 124
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 124
Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study 123
Aspirin as antiplatelet agent in diabetes. PROS-. 123
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes 122
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 122
Totale 15.348
Categoria #
all - tutte 111.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022940 0 0 0 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/20253.728 242 703 577 88 92 172 141 171 344 174 448 576
2025/20269.205 647 336 905 1.079 897 459 1.440 469 1.557 813 394 209
2026/20272.262 192 411 531 1.128 0 0 0 0 0 0 0 0
Totale 27.356